ANGPTL8 and metabolic syndrome: In females, compared to the lowest quartile of ANGPTL8/betatrophin levels (≤29.25 ng/mL), the risk of developing MetS in the three higher quartiles was also decreased (OR, 0.84; 95% CI, 0.74–0.96, p = 0.010).